Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Biogen’s Quarterly Earnings Preview: What You Need to Know

Biogen Inc. (BIIB), based in Cambridge, Massachusetts, has a market capitalization of approximately $33.3 billion. Founded in 1978, the biotechnology company discovers, develops, manufactures, and commercializes innovative medicines for neurological, neurodegenerative, autoimmune, and rare diseases, leveraging scientific research to improve patient outcomes and drive long-term growth.

BIIB is set to report its Q3 earnings on Wednesday, October 28, 2026, before the market opens. Ahead of the release, analysts expect the company to report diluted EPS of $2.10, down 56.3% from $4.81 in the year-ago quarter. That said, BIIB has exceeded Wall Street’s EPS estimates in each of the past four quarters, highlighting its consistent earnings performance.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.